Newsroom

PORTLAND, Maine--(BUSINESS WIRE)--WEX (NYSE: WEX) (“WEX” or the “Company”), a global leader in intelligent payment solutions, today publicized a letter to shareholders highlighting the Company’s strong performance, accelerating momentum and improved financial outlook for 2026. The full text of the letter follows: Dear Fellow Shareholders: This year’s Annual Meeting of Stockholders (the “Annual Meeting”) of WEX Inc. (“WEX,” “we,” or the “Company”) is fast approaching. The meeting is scheduled to...

SAN ANTONIO, Texas--(BUSINESS WIRE)--The Department of the Air Force, in conjunction with the Defense Innovation Unit, has selected Antares for the proposed deployment of a prototype nuclear microreactor at Joint Base San Antonio under the Advanced Nuclear Power for Installations (ANPI) initiative. "We're grateful and proud to partner with Joint Base San Antonio, the Department of the Air Force, and the Defense Innovation Unit," said Jordan Bramble, CEO and founder of Antares. "We built this co...

LONDRES et PARIS--(BUSINESS WIRE)--onefinestay a annoncé aujourd’hui une évolution stratégique de son portefeuille mondial, affinant sa présence sur les principaux marchés métropolitains tels que Londres, Paris, New York et Los Angeles, tout en se concentrant sur une sélection plus restreinte de résidences haut de gamme dans des destinations de loisirs très prisées en Europe, dans les Caraïbes et aux États-Unis. Cette initiative intervient alors que onefinestay poursuit son évolution au sein de...

PHOENIX--(BUSINESS WIRE)--Pinnacle West declared a quarterly dividend of $0.91 per share of common stock, payable on June 1, 2026, to shareholders of record on May 4, 2026....

NEW YORK--(BUSINESS WIRE)--Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP (“BLB&G”) filed a class action in the U.S. District Court for the Middle District of Tennessee alleging violations of the federal securities laws by LKQ Corporation (“LKQ” or the “Company”) and certain of the Company’s current and former senior executives (collectively, “Defendants”). The action is brought on behalf of all investors who purchased or otherwise acquired LKQ commo...

HOUSTON--(BUSINESS WIRE)--Helix Energy Solutions Group, Inc. ("Helix") (NYSE: HLX) reported a net loss of $13.4 million, or $(0.09) per diluted share, for the first quarter 2026 compared to net income of $8.3 million, or $0.06 per diluted share, for the fourth quarter 2025 and net income of $3.1 million, or $0.02 per diluted share, for the first quarter 2025. Net income during the fourth quarter 2025 included a non-cash impairment charge for certain of our oil and gas properties of approximatel...

SOUTHBOROUGH, Massachusetts--(BUSINESS WIRE)--Veristat (la «Compañía»), una organización de investigación por contrato (CRO) y consultora que ofrece servicios integrales en el ámbito científico e impulsa el avance de terapias complejas desde el desarrollo de fármacos hasta su presentación ante las autoridades regulatorias, acaba de anunciar su intención de adquirir la unidad de redacción médica y regulatoria de Certara. El equipo que se incorporará a Veristat es reconocido por sus servicios de...

SOUTHBOROUGH, Massachusetts--(BUSINESS WIRE)--Veristat (l'"Azienda"), una CRO e società di consulenza a servizio completo incentrata sulla scienza che promuove terapie complesse durante il ciclo di vita dello sviluppo di farmaci fino all'invio normativo, ha annunciato oggi l'intenzione di acquisire l'attività di redazione di documenti normativi e medici di Certara. Il team che si unirà a Veristat è noto per i suoi servizi di consulenza di altissimo livello e per le competenze approfondite nella...

SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Veristat (het “Bedrijf”), een full-service CRO die wetenschap voorop stelt en een consultancy die complexe therapieën bevordert tijdens de hele levenscyclus gaande van ontwikkeling van geneesmiddelen tot indiening van de aanvraag voor regelgevende toelating, kondigde vandaag zijn beoogde overname van Certara’s Regulatory & Medical Writing activiteit aan. Het team dat zich bij Veristat zal voegen, staat bekend voor zijn bureaucratische adviesdiensten en...

SOUTHBOROUGH, Massachusetts--(BUSINESS WIRE)--Veristat (la « société »), CRO et société de conseil full-service axée sur la science, qui accompagne le développement de thérapies complexes tout au long du cycle de développement des médicaments jusqu’au dépôt des dossiers réglementaires, a annoncé aujourd’hui son intention d’acquérir les activités d’affaires réglementaires et de rédaction médicale de Certara. L’équipe appelée à rejoindre Veristat est reconnue pour ses services de conseil à forte...